Contract 36F79718D0414
Neurocrine Biosciences, Inc. · Department Of Veterans Affairs · September 22, 2021
Neurocrine Biosciences, Inc. was awarded a federal contract by Department Of Veterans Affairs on September 22, 2021 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on November 17, 2025. If all options are exercised, the contract could reach $6.58 million.
Contract details
- PIID
- 36F79718D0414
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 22, 2021
- Latest action
- November 17, 2025
Description
2026 PUBLIC LAW PRICING UPDATE
Modification timeline
-
November 17, 2025Mod P00032 · Supplemental Agreement For Work Within Scope$0
-
October 27, 2025Mod P00031 · Supplemental Agreement For Work Within Scope42-2A PRODUCT ADDITION (CRENESSITY)$0
-
August 20, 2025Mod P00030 · Supplemental Agreement For Work Within ScopeTEMPORARY CONTRACT EXTENSION FROM 09/01/2025 TO 08-31-2026$0
-
September 4, 2024Mod P00022 · Supplemental Agreement For Work Within ScopeFSS$0
-
September 22, 2021Mod P00011 · Supplemental Agreement For Work Within ScopePRODUCT ADDITION AT TEMPORARY FCP.$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79718D0414?
Contract 36F79718D0414 is a federal contract awarded to Neurocrine Biosciences, Inc. by Department Of Veterans Affairs on September 22, 2021 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 4 times since the base award.
Who won contract 36F79718D0414?
Neurocrine Biosciences, Inc. won contract 36F79718D0414 from Department Of Veterans Affairs.
How much is contract 36F79718D0414 worth?
Contract 36F79718D0414 has obligated $0 to date but carries a potential ceiling of $6.58 million if fully funded and all options are exercised.